✦ LIBER ✦

Preoperative serum interleukin-18 level as a postoperative prognostic marker in patients with gastric carcinoma

✍ Scribed by Toshinobu Kawabata; Takashi Ichikura; Takashi Majima; Shuhji Seki; Kentaro Chochi; Eiji Takayama; Hoshio Hiraide; Hidetaka Mochizuki

Publisher: John Wiley and Sons
Year: 2001
Tongue: English
Weight: 91 KB
Volume: 92
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(20011015)92:8<2050::aid-cncr1544>3.0.co;2-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum CA 125 level as a predictor of per

Serum CA 125 level as a predictor of peritoneal dissemination in patients with gastric carcinoma

✍ Bunzo Nakata; Kosei Hirakawa-YS Chung; Yasuyuki Kato; Yoshito Yamashita; Kiyoshi 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 2 views

## BACKGROUND. Prediction of peritoneal dissemination is very difficult using current diagnostic tools such as computed tomography, ultrasonography, or various tumor markers. The predictive value of serum CA 125 levels for peritoneal metastasis from gastric carcinoma was studied. ## METHODS. Th

High level of urokinase-type plasminogen

High level of urokinase-type plasminogen activator is a new prognostic marker in patients with gastric carcinoma

✍ Jae Yong Cho; Hyun Cheol Chung; Sung Hoon Noh; Jae Kyung Roh; Jin Sik Min; Byung 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 1 views

defined risk factor in patients with gastric carcinoma. ## METHODS. Enzyme-linked immunoadsorbent assays were used to test for uPA anti-

Changes in tumor marker levels as a pred

Changes in tumor marker levels as a predictor of chemotherapeutic effect in patients with gastric carcinoma

✍ Bunzo Nakata; Kosei Hirakawa-Y. S. Chung; Kazuya Muguruma; Yoshito Yamashita; Th 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 235 KB 👁 1 views

## BACKGROUND. Evaluating chemotherapeutic effect in patients with gastric carcinoma sometimes is difficult. The authors investigated whether changes in the serum levels of three tumor markers can be used to predict the clinical outcome after chemotherapy. ## METHODS. Thirty patients with advance

Study of pretreatment serum levels of HE

Study of pretreatment serum levels of HER-2/neu oncoprotein as a prognostic and predictive factor in patients with advanced nonsmall cell lung carcinoma

✍ Andrea Ardizzoni; Mara A. Cafferata; Michela Paganuzzi; Rosangela Filiberti; Pao 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 2 views